Shorts

Who Gets to Decide the Gold Standard in AI-Systematic Literature Reviews: Lizheng Shi, PhD

The Future of Transplant Medicine: Karilyn Larkin, MD

The Reality of Stocking High-Cost Medications: Scott A. Soefje, PharmD, MBA

Lucio N. Gordan, MD, Explains the Difficulties of Clinical Research

Promising New Therapies for Richter Transformation: Adam S. Kittai, MD

The Barries to Value-Based Pricing in CMS: Peter Neumann, ScD

Liquid Biopsies Reshape Precision Medicine: Lori Brisbin, MS, MLS

All-Oral Bedaquiline Regimen Offers New Option for Refractory MAC

How AI Is Revolutionizing Cancer Drug Development: David Spigel, MD

ENCORE Trial Takeaways: No Longer A Waiting Game

Can You Tell the Difference: Flu vs COVID Symptoms in Kids

Future Challenges in CPFE Research, Treatment: Yet Khor, MD, PhD

The Changing Treatment Landscape in Myeloma: Swarup Kumar, MD

The Hidden Biases in Clinical Trial Criteria: Karilyn Larkin, MD

Expanding Treatment Access Via Academic-Community Ties: Amandeep Godara, MBBS

Bridging Geographic Gaps in Specialized Cancer Care: Christos Vaklavas, MD

Expanding NSCLC Biomarker Testing Access: Shiven B. Patel, MD, MBA

Grocery Assistance Supports Better Diabetes Outcomes: Jeff Romine, PhD

The Economic Impact of GLP-1 Discontinuation: Adam Colborn, JD

Employers Choose GLP-1 Coverage Over Rising Hospital Costs: Adam Colborn, JD

Multidisciplinary Care in COVID-19: Marc A. Sala, MD

Why Bronchiectasis Is a Neglected Lung Disease: Marc A. Sala, MD

Is Your Chronic Cough Actually Long COVID? Marc A. Sala, MD

Stopping the Exodus of Women Physicians: Bhavana Bhatnagar, DO

Targeting Lifestyle Factors for MASLD Management: Zobair M. Younossi, MD

Pharmacists Gain Reimbursement Through Expanded Coverage Mandates: Sally Rafie, PharmD

The Reality of Choosing Not to Vaccinate: Paul A. Offit, MD

Vaccine Exemption Abuse Drives Childhood Immunization Gaps: William Schaffner, MD

Pharmacy Access to Medication Abortion Care: Sally Rafie, PharmD

Atacicept's Favorable Safety Profile May Distinguish It Among IgA Nephropathy Therapies: Richard Lafayette, MD